Lothar Matheus Manson Vanende Silalahi


Background: Ischaemic stroke is caused by various aetiology. Cryptogenic stroke diagnosis is established when no aetiologies are discovered although clinical manifestations are consistent with acute stroke. Diffusion-weighted magnetic resonance imaging (DW-MRI) is one neuroimaging modalities which could be useful in exploring aetiology instead of excluding intracranial haemorrhage. There are many conflicting pieces of evidence of the benefit using DW-MRI to confirm the presence or the absence of brain lesions.
Objective: To report a clinical case of ischemic stroke with negative evaluation on advanced neuroimaging studies (DW-MRI).
Case Description: A female, 35 years old, presented to the emergency unit with a 6 hours history of prickling sensation before admission. There were no risk factors of stroke, and no other neurological symptoms. The neurologic examination reveals left hemihypesthesia, with normal results on laboratory examination for stroke risk factors and negative ischemic lesion on brain DW-MRI. Explorative examination on cardiac aetiologies was negative. Patient was given a standard regimen for acute stroke management despite the negative results and established as a cryptogenic stroke case.
Conclusion: Diagnosis of ischemic stroke should rely mainly on clinical findings, with consideration of cryptogenic stroke when there is no aetiology found after thorough examination. Nevertheless, comprehensive examination on cardiac function and coagulation tests should be performed whenever possible to determine the cause of ischaemic stroke.


brain ischaemia, stroke, cryptogenic, diffusion magnetic resonance imaging

Full Text:



Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke [Internet]. 2018 Mar;49(3).

Edlow BL, Hurwitz S, Edlow JA. Diagnosis of DWI-negative acute ischemic stroke: A meta-analysis. Neurology. 2017 Jul 18;89(3):256–62.

Marnane M, Duggan CA, Sheehan OC, Merwick A, Hannon N, Curtin D, et al. Stroke Subtype Classification to Mechanism-Specific and Undetermined Categories by TOAST, A-S-C-O, and Causative Classification System: Direct Comparison in the North Dublin Population Stroke Study. Stroke. 2010 Aug;41(8):1579–86.

Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35–41.

Yaghi S, Elkind MSV. Cryptogenic stroke: A diagnostic challenge. Neurol Clin Pract. 2014 Oct 1;4(5):386–93.

Ferro JM. Ischaemic stroke of undetermined cause. Lancet Neurol. 2015 Sep;14(9):871–2.

Yaghi S, Bernstein RA, Passman R, Okin PM, Furie KL. Cryptogenic Stroke: Research and Practice. Circ Res. 2017 Feb 3;120(3):527–40.

Arauz A, Merlos-Benítez M, Roa LF, Hernández-Curiel B, Cantú C, Murillo L, et al. Cryptogenic stroke in young patients: Long-term prognosis and recurrence. Neurol Engl Ed. 2011;26(5):279–84.

Nouh A, Hussain M, Mehta T, Yaghi S. Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol. 2016;7:37.

Saver JL. Cryptogenic Stroke. Solomon CG, editor. N Engl J Med. 2016 May 26;374(21):2065–74.

Zhang C, Kasner S. Diagnosis, prognosis, and management of cryptogenic stroke. F1000Research. 2016 Feb 12;5:168.

Hart RG, Diener H-C, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014 Apr;13(4):429–38.

Dalen JE, Alpert JS. Silent Atrial Fibrillation and Cryptogenic Strokes. Am J Med. 2017 Mar;130(3):264–7.

Mojadidi MK, Zaman MO, Elgendy IY, Mahmoud AN, Patel NK, Agarwal N, et al. Cryptogenic Stroke and Patent Foramen Ovale. J Am Coll Cardiol. 2018 Mar;71(9):1035–43.

Bang OY, Ovbiagele B, Kim JS. Evaluation of Cryptogenic Stroke With Advanced Diagnostic Techniques. Stroke. 2014 Apr;45(4):1186–94.

Dilaveris PE, Kennedy HL. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact: Silent Atrial Fibrillation. Clin Cardiol. 2017 Jun;40(6):413–8.

Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et al. Atrial Fibrillation in Patients with Cryptogenic Stroke. N Engl J Med. 2014 Jun 26;370(26):2467–77.

American Stroke Association. Understanding Diagnosis and Treatment of Cryptogenic Stroke. American Stroke Association; 2019.

Schellinger PD, Bryan RN, Caplan LR, Detre JA, Edelman RR, Jaigobin C, et al. Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2010 Jul 13;75(2):177–85.

Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Clinically Confirmed Stroke With Negative Diffusion-Weighted Imaging Magnetic Resonance Imaging: Longitudinal Study of Clinical Outcomes, Stroke Recurrence, and Systematic Review. Stroke. 2015 Nov;46(11):3142–8.

National Institute for Health and Care Excellence. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. National Institute for Health and Care Excellence; 2020.

Yang Y, Wang A, Zhao X, Wang C, Liu L, Zheng H, et al. The Oxfordshire Community Stroke Project classification system predicts clinical outcomes following intravenous thrombolysis: a prospective cohort study. Ther Clin Risk Manag. 2016 Jun;12:1049–56.

DOI: http://dx.doi.org/10.21460/bikdw.v5i1.165


  • There are currently no refbacks.

Copyright (c) 2020 Berkala Ilmiah Kedokteran Duta Wacana

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.